A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis | Zendy

Tomohiro  Handa | Zendy; Arata  Azuma | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Author(s) -

Tomohiro Handa,

Arata Azuma

Publication year - 2014

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmx140048

Subject(s) - pirfenidone , medicine , idiopathic pulmonary fibrosis , pulmonary fibrosis , fibrosis , dermatology , gastroenterology , surgery , lung

Proteomic Profiling Reveals Autoimmune Targets in Sarcoidosis. 5 Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients with Suspected Cardiac Sarcoidosis. 5 Bosentan for Sarcoidosis-Associated Pulmonary Hypertension: A Double-Blind Placebo Controlled Randomized Trial. 6 Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration vs Conventional Transbronchial Needle Aspiration in the Diagnosis of Sarcoidosis. 7 APSR EDUCATION PUBLICATION Newsletter Date: September 2015 Volume 7, Issue 9 APSR RESPIRATORY UPDATES

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research